“ D-α-tocopherol prevented the glucose-stimulated increases in DAG level and PKC activity as well as the amount of PKC βII isoform in ASMCs cultured with elevated glucose levels.”
“Intraperitoneal injection of D-α-tocopherol (40 mg/kg) every other day resulted in a significant decrease of the elevated membranous PKC specific activity and total DAG levels in parallel with a significant increase of D-α-tocopherol content in the aorta.”